跳至主要内容
临床试验/CTRI/2024/05/068040
CTRI/2024/05/068040尚未招募2 期

Evaluation of the therapeutic effectiveness of Siddhar Yogam and Munthirigai chooranam in the management of Kurthi Azhal noi (Primary Hypertension) patients reporting at Ayothidoss Pandithar Hospital of National Institute of Siddha, Chennai-A Comparative Non-randomized Double arm Clinical trial

National Institute of Siddha1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年6月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
40
试验地点
1
主要终点
The outcome of the study will be assessed by reduction in Systolic Blood pressure less than 85

研究概览

简要总结

Hypertension is one among the lifestyle modification disorders. Hypertension also known as high or raised blood pressure that can increase the risk of heart, brain, kidney and other diseases. In the Siddha concept, it is correlated to the Kuruthi azhal noi.Hence considerably more patients of Hypertension have been recorded in the Ayothiyadoss pandithar hospital, the Siddha formulation Munthirigai chooranam is said to be cost effective, simple formulation and has anti-hypertensive, diuretic and antioxidant property. Yogasanam plays an important role in the management of Hypertension, yogam reduces perceived stress and exerts positive effects on blood pressure. Yoga and meditative practices, including mindfulness-based interventions, provide the tools to manage this cardiovascular reactivity through restoration of psycho physiological balance. So, I hope Yogasanam and Munthinigai chooranam will be effective in the treatment of hypertension.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Primary hypertension Grade 1 hypertension: SBP 140 to 159mmHg and/or DBP 90 to 99mmHg 2.Patients who are willing to provide blood sample for investigation before and after treatment.
  • 3.Patient who are willing to sign in the consent form.

排除标准

  • 1.Secondary hypertension 2.Obesity (BMI-30 and above) 3.Pregnancy and Lactation 4.Alcoholism and Smoking 5.Patient with any other severe systemic disorder.

结局指标

主要结局

The outcome of the study will be assessed by reduction in Systolic Blood pressure less than 85

时间窗: SCREENING - 3 MONTHS | PATIENT ENROLLMENT - 5 MONTHS | TRIAL DRUG - 2 MONTHS | DATA ANALYSIS - 1 MONTHS | FOLLOW UP - 3 MONTHS

and Diastolic Blood pressure less than 130 after the treatment.

时间窗: SCREENING - 3 MONTHS | PATIENT ENROLLMENT - 5 MONTHS | TRIAL DRUG - 2 MONTHS | DATA ANALYSIS - 1 MONTHS | FOLLOW UP - 3 MONTHS

次要结局

未报告次要终点

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr P Manivannan

National Institute of Siddha

研究点 (1)

Loading locations...

相似试验